Intracellular Th Stock In The News

ITCI Stock  USD 127.02  0.02  0.02%   
Our overall analysis of Intracellular's news coverage and content from conventional and social sources shows investors' bearish mood towards Intracellular Th. The specific impact of Intracellular news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Intracellular's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Intracellular headlines in addition to utilizing other, more conventional financial analysis modules. Check out Intracellular Backtesting and Intracellular Hype Analysis.

Intracellular Today Top News and Investor Outlook

Yahoo News
Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now
https://finance.yahoo.com/news/why-intra-cellular-therapies-itci-082731828.html
 Bullish
Yahoo News
Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now
https://finance.yahoo.com/news/why-intra-cellular-therapies-inc-112819233.html
 Bullish
Investors Business Daily at Macroaxis
Biotech Venture Investors Optimistic, But Uncertainties Persist
https://finance.yahoo.com/m/190e7c60-efd1-3d58-bd93-4634bcd237ab/biotech-venture-investors.html
 Neutral
Yahoo News
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
https://finance.yahoo.com/news/johnson-johnson-jnj-q4-2024-070204042.html
 Bullish
Yahoo News
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
https://finance.yahoo.com/news/downside-risk-from-talc-lawsuit-stelara-generic-competition-is-manageable-jnj-cfo-joe-wolk-170357819.html
 Neutral
Yahoo News
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
https://finance.yahoo.com/news/johnson--johnson-stock-down-despite-beat-on-full-year-q4-2024-earnings-152224387.html
 Neutral
Yahoo News
Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
https://finance.yahoo.com/news/johnson-johnson-q4-earnings-cancer-132109216.html
 Bullish
Macroaxis News: globenewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, HEES, SSTK on Behalf of Shareholders
https://www.globenewswire.com/news-release/2025/01/21/3012708/0/en/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-ENFN-ITCI-HEES-SSTK-on-Behalf-of-Shareholders.html
 Bullish
Yahoo News
Why Johnson & Johnson (JNJ) Is the Best Soaps and Cleaning Materials Stock to Invest In
https://finance.yahoo.com/news/why-johnson-johnson-jnj-best-193033949.html
 Bullish
Yahoo News
Why Intra-Cellular Therapies, Inc. (ITCI) Dominated Last Week’s Rally
https://finance.yahoo.com/news/why-intra-cellular-therapies-inc-180006888.html
 Bullish

Intracellular Th Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Intracellular and other traded companies coverage with news coverage. We help investors stay connected with Intracellular headlines for the 30th of January to make an informed investment decision based on correlating the impacts of news items on Intracellular Stock performance. Please note that trading solely based on the Intracellular Th hype is not for everyone as timely availability and quick action are needed to avoid losses.
Intracellular's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Intracellular Th investors visualize upcoming and past events in order to time the market based on Intracellular Th noise-free hype analysis.
Intracellular stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Intracellular earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Intracellular that are available to investors today. That information is available publicly through Intracellular media outlets and privately through word of mouth or via Intracellular internal channels. However, regardless of the origin, that massive amount of Intracellular data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Intracellular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intracellular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intracellular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intracellular alpha.

Intracellular Largest EPS Surprises

Earnings surprises can significantly impact Intracellular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-07
2024-06-30-0.19-0.160.0315 
2024-10-30
2024-09-30-0.2-0.25-0.0525 
2014-11-03
2014-09-30-0.28-0.220.0621 
2014-05-05
2014-03-31-0.23-0.170.0626 
2021-02-25
2020-12-31-0.85-0.760.0910 
2017-11-08
2017-09-30-0.62-0.530.0914 
View All Earnings Estimates

Intracellular Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Intracellular Th Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
17th of January 2025
HAREHOLDER ALERT The MA Class Action Firm Is Investigating the Merger -- CCNE, ITCI, ...
at gurufocus.com 
news
16th of January 2025
Intra-Cellular Therapies Hold Rating Reiterated at Needham Company LLC
at thelincolnianonline.com 
Yahoo News
15th of January 2025
The Zacks Analyst Blog Highlights JJ, Eli Lilly, GSK and Intra-Cellular
at finance.yahoo.com 
insidermonkey News
14th of January 2025
Why Intra-Cellular Led the Monday Upsurge
at insidermonkey.com 
Yahoo News
13th of January 2025
JJ buys Intra-Cellular in 14.6 billion deal, delving further into central nervous system d...
at finance.yahoo.com 
Yahoo News
31st of December 2024
Acquisition by Riggs Rory B of 215 shares of Intracellular at 83.52 subject to Rule 16b-3
at finance.yahoo.com 
Yahoo News
29th of November 2024
Why Is Intra-Cellular Up 2.2 percent Since Last Earnings Report
at finance.yahoo.com 
news
4th of November 2024
JPMorgan Chase Co. Forecasts Strong Price Appreciation for Intra-Cellular Therapies Stock
at thelincolnianonline.com 

Intracellular Investors Sentiment

The influence of Intracellular's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Intracellular. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intracellular's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Intracellular.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intracellular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intracellular's short interest history, or implied volatility extrapolated from Intracellular options trading.
When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
6.096
Quarterly Revenue Growth
0.39
Return On Assets
(0.07)
Return On Equity
(0.1)
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.